Core Scientific (CORZ) Total Current Liabilities (2020 - 2026)

Core Scientific has disclosed Total Current Liabilities across 7 years of filings, most recently posting $2.7 billion for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 386.53% year-over-year to $2.7 billion; the TTM figure through Jun 2026 stood at $2.7 billion (up 386.53% YoY), while the FY2025 annual figure was $781.4 million, up 480.7% from the prior year.
• Total Current Liabilities came in at $2.7 billion for Q2 2026 at Core Scientific, up from $2.7 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.7 billion in Q2 2026 to a low of $74.8 million in Q2 2024.
• Average Total Current Liabilities over 5 years is $646.2 million, with a median of $363.7 million recorded in 2022.
• Year-over-year, Total Current Liabilities surged 50006.93% in 2022 and plunged 75.74% in 2023.
• Over 5 years, Total Current Liabilities stood at $186.8 million in 2022, then surged by 161.48% to $488.4 million in 2023, then plunged by 72.45% to $134.6 million in 2024, then soared by 480.7% to $781.4 million in 2025, then soared by 250.37% to $2.7 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $2.7 billion in Q2 2026, $2.7 billion in Q1 2026, and $781.4 million in Q4 2025.